Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Ranked against 18 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDT | $1.4B | 51.3× | 30.7× | 2.9× | 31.2% | 43.8% | 5.9% | 13.8% | 13.8% | 0.0× | 51 |
| NUTX | $1.4B | 19.1× | 4.1× | 1.6× | 82.4% | 50.8% | 8.1% | 21.5% | 19.0% | -0.5× | 22 |
| RSKD | $1.1B | — | — | 3.3× | 5.2% | 51.7% | -8.0% | -9.4% | -9.4% | — | 9 |
| AHG | $1.1B | 126.0× | — | 78.0× | -6.4% | -0.1% | -135% | -10.3% | -10.3% | — | — |
| QNST | $996M | 12.4× | 24.2× | 0.8× | 18.3% | 11.3% | 6.3% | 25.1% | 20.7% | -1.5× | 41 |
| MAX | $873M | 37.8× | 43.8× | 0.8× | 28.8% | 15.0% | 2.3% | 616% | 16.3% | 4.8× | 22 |
| PAYS | $787M | 107.2× | 49.3× | 9.6× | 40.5% | 59.4% | 9.2% | 15.6% | 13.4% | -0.8× | 23 |
| PHR | $772M | 311.0× | 28.5× | 1.6× | 14.5% | — | 0.5% | 0.7% | 0.7% | -2.5× | 31 |
| CASS | $674M | 20.2× | — | 3.5× | 5.3% | — | 18.4% | 14.5% | 14.5% | — | 41 |
| PRTH | $647M | 11.5× | 7.9× | 0.7× | 8.3% | — | 5.8% | -55.5% | 5.9% | 4.7× | 20 |
| RMNI | $463M | 12.7× | 6.4× | 1.1× | -1.7% | 60.4% | 8.8% | -137% | 92.4% | -0.8× | 16 |
| FVRR | $302M | 15.0× | 13.1× | 0.7× | 10.1% | 81.6% | 4.9% | 5.1% | 5.1% | -9.3× | 23 |
| PSFE | $293M | — | 7.6× | 0.2× | -0.2% | 56.4% | -10.7% | -27.9% | -5.6% | 6.8× | — |
| IMXI | $277M | 8.5× | 4.2× | 0.5× | -7.7% | — | 5.4% | 20.3% | 9.2% | 0.4× | 22 |
| CNDT | $240M | — | — | 0.1× | -9.4% | 18.1% | -5.6% | -24.8% | -12.4% | — | 29 |
| ALIT | $236M | — | — | 0.1× | -3.0% | 33.8% | -137% | -297% | -102% | — | — |
| DHX | $196M | — | 77.8× | 1.5× | -9.9% | 84.7% | -10.6% | -14.3% | -10.9% | 9.4× | 7 |
| OPRX | $176M | 34.5× | 15.1× | 1.6× | 18.8% | 67.3% | 4.7% | 4.0% | 3.3% | 0.2× | 11 |
| SRCO | $4M | — | — | 11.4× | 46.6% | 91.9% | -826% | 21.4% | 21.4% | — | — |
Peers = companies sharing SRCO's sector (Services-Business Services, NEC) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow on any basis, so a reverse DCF can't be run.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $118K (at 2026-04-30) covers the $108K due within a year 1.1× over. Scheduled principal only (excludes interest & revolver draws). As of 2013-01-31 (10-Q). The cash figure is from 2026-04-30, so the two are not the same balance-sheet date — the schedule has not been refiled since.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~54183.4% on $2K of debt.
Cash of $118K fully covers short-term debt of $2K.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-29
How a revenue dollar becomes profit — FY2026
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $345K 100.0% | $236K 100.0% | $192K 100.0% | $257K 100.0% | $245K 100.0% | $260K 100.0% | $321K 100.0% | $385K 100.0% | $446K 100.0% | $548K 100.0% |
| Cost of Revenue | $28K 8.1% | $28K 12.0% | $37K 19.1% | $43K 16.7% | $51K 20.6% | $61K 23.5% | $60K 18.8% | $30K 7.7% | $43K 9.7% | $50K 9.0% |
| Gross Profit | $317K 91.9% | $207K 88.0% | $155K 80.9% | $214K 83.3% | $195K 79.4% | $199K 76.5% | $261K 81.2% | $355K 92.3% | $403K 90.3% | $498K 91.0% |
| Research & Development | — | — | — | — | $217K 88.5% | — | — | — | — | — |
| Selling, General & Admin | $222K 64.2% | $196K 83.2% | $185K 96.3% | $251K 97.9% | $896K 364.8% | $1.4M 537.0% | $1.1M 327.9% | $1.2M 312.1% | $1.2M 278.6% | $1.5M 270.3% |
| Total Operating Expenses | $2.4M 703.6% | $1.4M 608.1% | $1.0M 531.0% | $1.6M 624.2% | $1.9M 761.0% | $1.4M 537.0% | $1.1M 328.0% | $1.2M 312.5% | $1.2M 279.1% | $1.5M 270.7% |
| Operating Income | -$2.1M -611.8% | -$1.2M -520.1% | -$864K -450.2% | -$1.4M -540.9% | -$1.7M -681.6% | -$1.2M -460.5% | -$792K -246.9% | -$847K -220.2% | -$842K -188.8% | -$985K -179.8% |
| Interest Expense | $859K 248.7% | $657K 278.8% | $581K 302.4% | $528K 205.6% | — | — | — | — | — | — |
| Other Income (Expense), net | -$741K -214.6% | -$890K -377.7% | $257K 134.0% | $2.4M 941.7% | -$514K -209.4% | -$1.1M -421.4% | $19K 5.9% | $823K 214.0% | $2.0M 439.0% | $1.6M 289.6% |
| Net Income | -$2.9M -826.4% | -$2.1M -897.8% | -$607K -316.2% | $1.0M 397.2% | -$2.2M -894.5% | -$2.3M -877.1% | -$787K -245.4% | -$1.7M -439.1% | -$2.8M -636.5% | -$2.6M -475.4% |
| Per Share | ||||||||||
| EPS (Basic) | -$0.06 | -$0.06 | -$0.02 | $0.05 | -$0.16 | -$0.37 | — | — | — | — |
| EPS (Diluted) | -$0.06 | -$0.06 | -$0.02 | $0.05 | -$0.16 | — | — | — | — | — |
| Weighted Avg Shares (Basic) | 45.1M | 35.6M | 28.3M | 19.4M | 13.7M | 6.3M | — | — | — | — |
| Weighted Avg Shares (Diluted) | 45.1M | 35.6M | 28.3M | 19.4M | 13.7M | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-29
Where each multiple sits in its own 15-yr range · 50th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
ROE 21% against ROIC 21% — -0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.6× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 7.7 | 18.8 | 23.5 | 20.6 | 16.7 | 19.1 | 12.0 | 8.1 |
| Gross Profit | 92.3 | 81.2 | 76.5 | 79.4 | 83.3 | 80.9 | 88.0 | 91.9 |
| R&D | — | — | — | 88.5 | — | — | — | — |
| SG&A | 312.1 | 327.9 | 537.0 | 364.8 | 97.9 | 96.3 | 83.2 | 64.2 |
| Operating Income | -220.2 | -246.9 | -460.5 | -681.6 | -540.9 | -450.2 | -520.1 | -611.8 |
| Net Income | -439.1 | -245.4 | -877.1 | -894.5 | 397.2 | -316.2 | -897.8 | -826.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SRCO: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2017 | 91.0% | -179.8% | -475.4% |
| FY2018 | 90.3% | -188.8% | -636.5% |
| FY2019 | 92.3% | -220.2% | -439.1% |
| FY2020 | 81.2% | -246.9% | -245.4% |
| FY2021 | 76.5% | -460.5% | -877.1% |
| FY2022 | 79.4% | -681.6% | -894.5% |
| FY2023 | 83.3% | -540.9% | 397.2% |
| FY2024 | 80.9% | -450.2% | -316.2% |
| FY2025 | 88.0% | -520.1% | -897.8% |
| FY2026 | 91.9% | -611.8% | -826.4% |
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: tax_rate.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
This schedule comes from a filing dated 2013-01-31, 5021 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2013-01-31 (10-Q); cash from the 2026-04-30 balance sheet; FCF from FY2026.
Balance sheet at 2026-04-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda.
No positive free cash flow to discount, so the price cannot be expressed as a growth requirement.
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: free_cash_flow.